Skip to main content
SpringerLink
Log in

Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application

  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

There is increasing interest in the generation of dendritic cells (DC) for cancer immunotherapy. In order to utilize DC in clinical trials it is necessary to have standardized, reproducible and easy to use protocols. We describe here the process development for the generation of DC as the result of investigation of culture conditions as well as consumption rates of medium and cytokines. Our studies demonstrate that highly viable DC (93 ± 2%) can be produced from CD14+ enriched monocytes via immunomagnetic beads in a high yield (31 ± 6%) with X-VIVO 15, 400 U ml−1 GM-CSF and 2000 U ml−1 IL-4 without serum and feeding. For the maturation of DC different cocktails (TNF-α, IL-1β, IL-6, PGE2 and TNF-α, PGE2) were compared. In both cases cells expressed typical surface molecules of mature DC and induced high proliferative responses in mixed lymphocyte reactions which led to IFN-γ producing T-lymphocytes. The data suggest that the use of this optimized, easy to use protocol results in highly mature DC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Banchereau J. and Steinman R.M. 1998. Dendritic cells and the control of immunity. Nature 392: 245–252.

    Article  PubMed  CAS  Google Scholar 

  • BenderA., SappM., Schuler G., Steinman R.M. and Bhardwaj N. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Meth. 196: 121–135.

    Article  CAS  Google Scholar 

  • Berger T., Feuerstein B., Strasser E., Hirsch U., Schreiner D., Schuler G. and Schuler-Thurner B. 2002. Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J. Immunol. Meth. 268: 131–140.

    Article  CAS  Google Scholar 

  • Bernard J., Ittelet D., Christoph A., Potron G., Adjizian J.C., Kochman S. and Lopez M. 1998. Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use. Hematol. Cell Ther. 40: 17–26.

    PubMed  CAS  Google Scholar 

  • Bohnenkamp H.R. and Noll T. 2002. Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale. Cytotechnology 38: 135–145.

    Article  CAS  Google Scholar 

  • Caux C., Dezutter-Dambuyant C., Schmitt D. and Banchereau J. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360: 258–261.

    Article  PubMed  CAS  Google Scholar 

  • Costello R.T., Gastaut J.A. and Olive D. 1999. Tumor escape from immune surveillance. Arch. Immunol. Ther. Exp. 47: 83–88.

    CAS  Google Scholar 

  • Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C. and Bhardwaj N. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233–238.

    Article  PubMed  CAS  Google Scholar 

  • DietzA.B., BulurP.A., EricksonM.R., WettsteinP.J., LitzowM.R., Wyatt W.A., Dewald G.W., Tefferi A., Pankratz V.S. and Vuk-Pavlovic S. 2000. Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells. J. Hematother. Stem Cell Res. 9: 95–101.

    Article  PubMed  CAS  Google Scholar 

  • Dzionek A., Piechaczek C., Campbell J., Zysk M., Winkels G., Huppert V. and Schmitz J. 2002. Clinical-scale magnetic sorting and multiparamter analysis of dendritic cells aubsets and precursors. In: 7th International Symposium on Dendritic Cells, Bamberg.

  • Fong L., Hou Y., Rivas A., Benike C., Yuen A., Fisher G.A., Davis M.M. and Engleman E.G. 2001. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA 98: 8809–8814.

    Article  PubMed  CAS  Google Scholar 

  • Goxe B., Latour N., Chokri M., Abastado J.P. and Salcedo M. 2000. Simplified method to generate large quantities of dendritic cells suitable for clinical applications. Immunol. Invest. 29: 319–336.

    PubMed  CAS  Google Scholar 

  • Guyre C.A., Fisher J.L., Waugh M.G., Wallace P.K., Tretter C.G., Ernstoff M.S. and Barth R.J. 2002. Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications. J. Immunol. Meth. 262: 85–94.

    Article  CAS  Google Scholar 

  • Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J. and Enk A.H. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serumfree conditions.Eur. J. Immunol. 27: 3135–3142.

    PubMed  CAS  Google Scholar 

  • Kalinski P., Schuitemaker J.H., Hilkens C.M. and Kapsenberg M.L. 1998. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161: 2804–2809.

    PubMed  CAS  Google Scholar 

  • Kikuchi T., Akasaki Y., Irie M., Homma S., Abe T. and Ohno T. 2001. Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol. Immunother. 50: 337–344.

    Article  PubMed  CAS  Google Scholar 

  • Kobayashi T., Shinohara H., Toyoda M., Iwamoto S. and Tanigawa N. 2001. Regression of lymph node metastases by immunotherapy using autologous breast tumor-lysate pulsed dendritic cells: Report of a case. Surg. Today 31: 513–516.

    Article  PubMed  CAS  Google Scholar 

  • Kugler A., Stuhler G., Walden P., Zoller G., Zobywalski A., Brossart P., Trefzer U., Ullrich S., Muller C.A., Becker V., Gross A.J., Hemmerlein B., Kanz L., Muller G.A. and Ringert R.H. 2000. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat. Med. 6: 332–336.

    Article  PubMed  CAS  Google Scholar 

  • Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K.A., Maliszewski C., Shortman K., Cebon J. and Maraskovski E. 2002. Functionally distinct dendritic cell DC populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC Subsets. Blood 100: 1362–1372.

    Article  PubMed  CAS  Google Scholar 

  • Mackensen A., Herbst B., Chen J.L., Kohler G., Noppen C., Herr W., Spagnoli G.C., Cerundolo V. and Lindemann A. 2000. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int. J. Cancer 86: 385–392.

    Article  PubMed  CAS  Google Scholar 

  • Manz R., Assenmacher M., Pfluger E., Miltenyi S. and Radbruch A. 1995. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc. Natl. Acad. Sci. USA 92: 1921–1925.

    Article  PubMed  CAS  Google Scholar 

  • Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G. and Schadendorf D. 1998. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4: 328–332.

    Article  PubMed  CAS  Google Scholar 

  • O'Garra A. and Arai N. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10: 542–550.

    Article  PubMed  Google Scholar 

  • Patel S.D., Papoutsakis E.T., Winter J.N. and Miller W.M. 2000. The lactate issue revisited: Novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol. Prog. 16: 885–892.

    Article  PubMed  CAS  Google Scholar 

  • PicklW.F., Majdic O., Kohl P., Stockl J., Riedl E., ScheineckerC., Bello-Fernandez C. and Knapp W. 1996. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 157: 3850–3859.

    PubMed  CAS  Google Scholar 

  • Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M. and Schuler G. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83–93.

    Article  PubMed  CAS  Google Scholar 

  • Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D. and Schuler G. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Meth. 196: 137–151.

    Article  CAS  Google Scholar 

  • Sallusto F. and Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109–1118.

    Article  PubMed  CAS  Google Scholar 

  • Sallusto F. and Lanzavecchia A. 1999. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189: 611–614.

    Article  PubMed  CAS  Google Scholar 

  • Scandella E., Men Y., Gillessen S., Forster R. and Groetrp M. 2002. Prostaglandin E2 is a key factor for CCR7 surface expression and migartion of monocyte-derived dendritic cells. Blood 100: 1354–1361.

    Article  PubMed  CAS  Google Scholar 

  • Schuler-Thurner B., Schultz E.S., Berger T.G., Weinlich G., Ebner S., Woerl P., Bender A., Feuerstein B., Fritsch P.O., Romani N. and Schuler G. 2002. Rapid induction of tumorspecific type 1 helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptideloaded monocyte-derived dendritic cells. J. Exp. Med. 195: 1279–1288.

    Article  PubMed  CAS  Google Scholar 

  • Thurner B., Haendle I., Roder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., von den Driesch P., Brocker E.B., Steinman R.M., Enk A., Kampgen E. and Schuler G. 1999a. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669–1678.

    Article  PubMed  CAS  Google Scholar 

  • Thurner B., Roder C., Dieckmann D., Heuer M., Kruse M., Glaser A., Keikavoussi P., Kampgen E., Bender A. and Schuler G. 1999b. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J. Immunol. Meth. 223: 1–15.

    Article  CAS  Google Scholar 

  • Zhou L.J. and Tedder T.F. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821–3835.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center Juelich GmbH, Institute of Biotechnology 2, 52428, Juelich, Germany

    H.R. Bohnenkamp & T. Noll

Authors
  1. H.R. Bohnenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Noll
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Noll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bohnenkamp, H., Noll, T. Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application. Cytotechnology 42, 121–131 (2003). https://doi.org/10.1023/B:CYTO.0000015833.34696.03

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CYTO.0000015833.34696.03

Search

Navigation